Workflow
深振业、振业集团(000006) - 2025 Q4 - 年度业绩预告
2026-01-30 09:25
Financial Performance - The estimated net profit attributable to shareholders for 2025 is projected to be -50 million CNY, a 96.81% improvement compared to -156.84 million CNY in the previous year[6] - The net profit after deducting non-recurring gains and losses is expected to be -60 million CNY, reflecting a 96.18% increase from -156.97 million CNY year-on-year[6] - The basic earnings per share is forecasted to be -0.0370 CNY, compared to -1.1618 CNY in the same period last year[6] - The primary reason for the reduced loss is a significant decrease in asset impairment provisions compared to the previous year[8] - The projected net profit for 2025 is expected to remain negative, indicating ongoing challenges[4] Audit and Disclosure - The financial data presented in the earnings forecast has not been audited and is subject to final audit results[7] - The company has communicated with the accounting firm regarding the earnings forecast, and there are no significant discrepancies[7] - The company will provide detailed financial data in the 2025 annual report[9] Investor Guidance - The company warns investors to pay attention to the publicly disclosed information and to be aware of investment risks[9] - The performance forecast period is from January 1, 2025, to December 31, 2025[4]
皖通科技(002331) - 2025 Q4 - 年度业绩预告
2026-01-30 09:25
Financial Performance - The company expects a net profit of -368.17 million yuan for the year 2025, compared to -218.17 million yuan in the same period last year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses is projected to be -375.86 million yuan, down from -225.87 million yuan year-on-year[4] - The basic earnings per share is estimated to be -0.8716 yuan, compared to -0.5165 yuan in the previous year[4] Market Conditions - The decline in profit margins is attributed to intense market competition, which has compressed profit space[6] Expenses and Impairments - The company incurred approximately 46.11 million yuan in stock incentive expenses, negatively impacting net profit[7] - The acquisition of a 70% stake in Huadong Lisheng in 2023 resulted in goodwill of 106.05 million yuan, with an expected impairment provision of 98.41 million yuan due to underperformance[8] - The company is currently assessing potential asset impairments, including goodwill, with final amounts to be determined by external evaluators[9] Financial Reporting - The financial data presented is preliminary and has not been audited by an accounting firm; final figures will be disclosed in the 2025 annual report[10]
达实智能(002421) - 2025 Q4 - 年度业绩预告
2026-01-30 09:25
Financial Performance Expectations - The company expects a net profit in the range of -89,500,000 to -71,500,000 CNY for the fiscal year 2025, compared to a profit of 2,588,120 CNY in the same period last year[3] - The net profit after deducting non-recurring gains and losses is projected to be between -63,500,000 and -43,500,000 CNY, down from 159,550 CNY year-over-year[3] - Basic earnings per share are expected to be -0.4221 CNY, compared to -0.3372 CNY in the previous year[3] Reasons for Profit Decline - The decline in profit is attributed to a decrease in operating revenue and gross margin, as well as equity transfer and debt restructuring of project companies[5] - The decrease in operating revenue and gross margin is primarily due to delays in the implementation of signed projects and reductions in settlement amounts for certain large projects[5] Financial Data and Audit - The financial data in this earnings forecast has not been audited by a registered accounting firm, and the company has communicated with the auditing firm regarding this forecast[4] - Investors are advised to be cautious of investment risks as the financial data will be detailed in the company's 2025 annual report[6]
奥美医疗(002950) - 2025 Q4 - 年度业绩预告
2026-01-30 09:25
Financial Projections - The estimated net profit attributable to shareholders for 2025 is projected to be between CNY 215.50 million and CNY 257.50 million, representing a decline of 30.16% to 41.55% compared to the previous year[3]. - The estimated net profit attributable to shareholders after deducting non-recurring gains and losses is projected to be between CNY 179.50 million and CNY 221.50 million, reflecting a decrease of 35.49% to 47.72% year-over-year[3]. - Basic earnings per share for 2025 are expected to be between CNY 0.35 and CNY 0.41, down from CNY 0.59 in the previous year[3]. - The company plans to recognize impairment provisions for assets showing signs of impairment, which is expected to reduce the total profit for 2025 by CNY 208.63 million[5]. - The financial data in the earnings forecast has not been audited by the accounting firm and is based on preliminary estimates[6]. Business Strategy - The company aims to build a new business growth base by focusing on functional dressings and hygiene care products while expanding its overseas business to mitigate the impact of international trade conflicts[4]. Investor Communication - The company emphasizes the importance of timely information disclosure and advises investors to make cautious decisions and be aware of investment risks[7].
方大集团(000055) - 2025 Q4 - 年度业绩预告
2026-01-30 09:25
Financial Projections - The estimated net profit for 2025 is projected to be between -530 million and -380 million CNY, compared to a profit of 144.81 million CNY in the same period last year [5]. - The net profit after deducting non-recurring gains and losses is expected to be between -310 million and -160 million CNY, down from 159.78 million CNY year-on-year [5]. - Basic earnings per share are projected to be -0.49 CNY, compared to -0.35 CNY last year and 0.13 CNY in the previous year [5]. - The decline in fair value of investment properties is estimated to impact net profit by approximately -250 million to -180 million CNY, classified as non-recurring losses [7]. - Increased provision for bad debts in the curtain wall business due to difficulties in receivables recovery, leading to a higher provision amount compared to the previous year [8]. Revenue and Market Performance - Revenue from the curtain wall and materials business has decreased year-on-year due to intensified market competition, resulting in a decline in overall gross margin [8]. Strategic Initiatives - The company plans to enhance technological investment and promote new product innovation while focusing on digital and intelligent technologies to empower core operations [9]. - The company aims to expand overseas markets while maintaining domestic growth, implementing a "technology + service" dual model to improve market share and order quality [9]. - The company expresses confidence in significantly improving operational performance in 2026 [9]. Financial Disclaimer - The financial data presented is preliminary and subject to final confirmation in the 2025 annual report, urging investors to be aware of investment risks [9].
华兴源创(688001) - 2025 Q4 - 年度业绩预告
2026-01-30 09:25
Financial Performance - The company expects a net profit attributable to shareholders of approximately 85 million yuan for the year 2025, a turnaround from a net loss of 497.04 million yuan in the previous year[3] - The net profit attributable to shareholders after deducting non-recurring gains and losses is projected to be around 48 million yuan, compared to a loss of 534.01 million yuan in the previous year[3] - The total profit for the previous year was -488.90 million yuan, with a net profit attributable to shareholders of -497.04 million yuan[4] Factors Influencing Performance - The company attributes the performance improvement to a mild recovery in the consumer electronics industry and the growth of artificial intelligence technology, along with supportive national subsidy policies[5] - The company has significantly reduced asset impairment losses compared to the previous year[5] Strategic Plans - The company plans to enhance market expansion efforts and optimize product structure to drive continuous business growth[5] - The subsidiary, Suzhou Huaxing Oulitong Automation Technology Co., Ltd., is expected to achieve revenue and net profit growth in 2025, with no anticipated goodwill impairment[5] Forecast Accuracy - There are no major uncertainties affecting the accuracy of the performance forecast as of the announcement date[6] - The forecast data is preliminary and subject to final audited figures in the official 2025 annual report[7]
传智教育(003032) - 2025 Q4 - 年度业绩预告
2026-01-30 09:25
Financial Performance - The company expects a net profit loss of between ¥7,000.00 million and ¥10,000.00 million for the fiscal year 2025, compared to a loss of ¥13,392.34 million in the previous year[3] - Projected operating revenue for 2025 is estimated to be between ¥36,000.00 million and ¥40,000.00 million, up from ¥24,566.34 million in the same period last year[3] - The total profit is expected to be a loss of between ¥9,000.00 million and ¥12,000.00 million, an improvement from a loss of ¥12,546.30 million in the previous year[3] - The company's total equity attributable to shareholders is projected to be between ¥116,000.00 million and ¥119,000.00 million at the end of the fiscal year, down from ¥125,878.64 million at the end of the previous year[3] - The financial data presented is preliminary and subject to final confirmation in the 2025 annual report[8] Business Development - The company has launched a new generation of intelligent training system courses, integrating advanced technologies such as large model fine-tuning and application development[6] - The company has established the Datong Data Technology Vocational College, which offers six digital majors, marking a significant step in its domestic education business[6] - The acquisition of Singapore Fu Ren International School was completed in January 2025, enhancing the company's asset quality and supporting its international business expansion[6] - The company is implementing a dual-track development strategy focusing on "digital talent vocational training + academic education" to stabilize and grow its business lines[5] Asset Management - The company plans to conduct impairment testing on various assets and may recognize impairment provisions based on prudent principles[7]
太钢不锈(000825) - 2025 Q4 - 年度业绩预告
2026-01-30 09:25
证券代码:000825 证券简称:太钢不锈 公告编号:2026-001 山西太钢不锈钢股份有限公司 2025 年度业绩预告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、 误导性陈述或重大遗漏。 一、本期业绩预计情况 (一)业绩预告期间 2025 年 1 月 1 日至 2025 年 12 月 31 日 公司本次业绩预告未经会计师事务所审计。公司就本次业绩预告 有关事项与会计师事务所进行了预沟通,双方在业绩预告方面不存在 分歧。 三、业绩变动原因说明 2025 年,钢铁行业步入减量调结构深度转型阶段,面对复杂的 市场环境,公司坚持对标找差,通过整合铁前、炼钢生产资源,推进 集约化生产,持续提升产线运行效率;聚焦原料配比结构优化、能源 回收利用及技经指标提升,降本增效成效显著;深化以客户为中心、 以市场为导向的运营机制建设,推动产销研一体化变革,围绕 QCDVS (质量、成本、交付、品种及服务)与市场、客户深度对接,改善客 户满意度。得益于上述系列举措,公司 2025 年度经营业绩稳步改善。 2025 年预计非经常性损益为 10500 万元-11500 万元,主要是计 入当期损益的政府补 ...
胜通能源(001331) - 2025 Q4 - 年度业绩预告
2026-01-30 09:25
证券代码:001331 证券简称:胜通能源 公告编号:2026-011 胜通能源股份有限公司 2025 年度业绩预告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚 假记载、误导性陈述或重大遗漏。 一、本期业绩预计情况 1.业绩预告期间 2025 年 1 月 1 日至 2025 年 12 月 31 日 2.业绩预告情况 预计的业绩:预计净利润为正值且属于扭亏为盈情形 | 项目 | | 本报告期 | | 上年同期 | | | --- | --- | --- | --- | --- | --- | | 归属于上市公司股东的净利润 | 1,500 | 万元~1,950 | 万元 | -1,689.11 | 万元 | | 扣除非经常性损益后的净利润 | -2,150 | 万元~-1,550 | 万元 | -1,795.09 | 万元 | | 基本每股收益 | 0.0531 | 元/股~0.0691 | 元/股 | -0.0838 | 元/股 | 二、与会计师事务所沟通情况 本次业绩预告相关财务数据是公司财务部门初步测算的结果,未经会计师事 务所预审计。公司就本次业绩预告有关事项与为公司提供年度审计服 ...
亚太药业(002370) - 2025 Q4 - 年度业绩预告
2026-01-30 09:25
Financial Performance - The net profit attributable to shareholders for 2025 is expected to be between 100 million and 120 million CNY, representing a growth of 192.06% compared to the previous year's profit of 34.24 million CNY [2]. - The net profit after deducting non-recurring gains and losses is projected to be a loss of 42 million to 60 million CNY, a decrease of 49.30% compared to the previous year's loss of 28.13 million CNY [2]. - Basic earnings per share are expected to be between 0.13 CNY and 0.16 CNY, compared to 0.05 CNY in the previous year [2]. - Operating revenue is forecasted to be between 350 million and 370 million CNY, down from 405.17 million CNY in the previous year [2]. Factors Influencing Profit - The increase in net profit is primarily due to the sale of 100% equity in a wholly-owned subsidiary, which added approximately 149 million CNY to the total profit for 2025 [5]. - Excluding non-recurring items, the decline in net profit is attributed to decreased sales revenue due to intensified market competition and centralized procurement [5]. - The company incurred additional financial expenses due to the redemption of convertible bonds at 115% of their face value, which matured on April 2, 2025 [5]. - A provision for impairment of 10.14 million CNY was made for the "R- ketoprofen sustained-release patch" project due to uncertainties in obtaining new drug certification [5]. Financial Reporting and Investor Advisory - The financial data presented is preliminary and has not been audited by the accounting firm, with final figures to be disclosed in the 2025 annual report [6]. - Investors are advised to exercise caution and consider investment risks based on the preliminary financial estimates [6].